Skip to main content
OpenTrials

Clinical trial condition

Pneumococcal Infections

Explore clinical trials studying Pneumococcal Infections. Study availability and eligibility vary by location and protocol.

273 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Pneumococcal Infections trial results

Completed

A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan

NCT05512819

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Nirmal Hospital Pvt Ltd. Surat, Gujarat, India
  • BGS Global Institute of Medical Sciences (BGSGIMS) Bangalore, Karnataka, India
  • Bharati Vidyapeeth {Deemed to be University) Medical College Hospital & Research Centre Pune, Maharashtra, India
  • Maulana Azad Medical College and Associated with Lok Nayak Hospital New Delhi, National Capital Territory of Delhi, India
View Trial Details
Completed

Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.

NCT05060146

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • CH Alès Cévennes Alès, France
  • CH de Bagnols sur Cèze Bagnols-sur-Cèze, France
  • CH de Montauban Montauban, France
  • CHU de Montpellier Montpellier, France
View Trial Details
Completed

A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

NCT05412030

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Pensacola, Florida, United States
View all 46 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

NCT05844423

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +8 more
Locations
  • The Children's Clinic of Jonesboro, P.A. Jonesboro, Arkansas, United States
  • Madera Family Medical Group Madera, California, United States
  • Jedidiah Clinical Research Tampa, Florida, United States
  • Kentucky Pediatric/ Adult Research Bardstown, Kentucky, United States
View all 32 locations
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)

NCT05158140

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations
  • Carbon Health ( Site 0045) North Hollywood, California, United States
  • Valley Clinical Trials Inc. ( Site 0002) Northridge, California, United States
  • Center for Clinical Trials, LLC ( Site 0022) Paramount, California, United States
  • Artemis Institute for Clinical Research ( Site 0024) San Diego, California, United States
View all 46 locations
View Trial Details

Related conditions